Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-13

FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved the original ANDA for Prochlorperazine Edisylate from Somerset Therapeutics, LLC, authorizing its marketing as an antiemetic for nausea and vomitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prochlorperazine edisylate (Prochlorperazine edisylate)

Snippet

ORIG AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)